We aim to be a comprehensive resource for the Australian research community
Your clinician can also advise on optimal timing and dosing to maximise symptom relief whilst maintaining the effectiveness of your weight management treatment
The ERK1/2 pathway activation by BPC-157 leads to increased cellular proliferation, migration, and vascular tube formation
GLP-1 studies show improved A1C, body weight, and more GLP-1s and other incretin agents have shown promising results in type 1 diabetes, especially in terms of weight loss
Contact your GP surgery or call NHS 111 for advice , especially if you experience severe nausea, persistent vomiting (lasting more than 24 hours), inability to keep fluids down, reduced urine output, dizziness, severe abdominal pain, or signs of hypoglycaemia (low blood sugar)